Core Insights - Dawn Health has completed a €21.5 million growth investment round with Cipio Partners joining existing investors to support its expansion in AI-driven digital health solutions [1][2][3] - The investment aims to enhance product innovation and value creation for pharmaceutical partners, leveraging Dawn Health's established platform and ecosystem [2][4] - Cipio Partners recognizes Dawn Health's potential as a long-term leader in regulated digital health, emphasizing the opportunity to scale its SaaS offerings and expand into clinical trials [3][4] Company Overview - Dawn Health is a global digital health company that collaborates with pharmaceutical companies to develop and scale regulated digital solutions, including AI-enabled products [6] - The company focuses on supporting patients, healthcare professionals, and pharma teams across various areas such as clinical trials and real-world evidence generation [6] - Dawn Health's technology is designed to improve patient engagement and facilitate compliant data collection beyond clinical settings [6] Investment Details - The investment from Cipio Partners is part of a broader strategy to build scalable and compliant digital health products that support the entire pharmaceutical value chain [4] - Cipio Partners specializes in growth capital and minority buyouts for technology companies, targeting businesses with revenues between €10-50 million [5]

Group 1 - Dawn Health has secured EUR 11.5 million in funding from existing investors to scale its platform and product suite for next-generation pharmaceutical digital health solutions [1] - The company has developed a platform tailored for the pharmaceutical industry, which has been adopted by major players like Merck and Novartis [2] - The Dawn Platform enhances patient care and outcomes through advanced capabilities in AI, data analytics, and clinical integrations, supporting therapy companions and disease management programs [3] Group 2 - The CEO of Dawn Health emphasized the ambition to lead in digital health and improve patient lives globally, with the new funding aimed at expanding market reach [4] - Since a major investment in December 2021, Dawn Health has significantly increased its revenue and workforce, now employing over 100 people [5] - Dawn Health specializes in Software as a Medical Device (SaMD) and Digital Therapeutics (DTx), focusing on chronic conditions and patient-centric solutions [6]